comparemela.com

Latest Breaking News On - Colin kellaher - Page 14 : comparemela.com

Equinix Gets Subpoena as Board Examines Short Seller s Claims

By Colin Kellaher Equinix, the target of a recent short-seller s report accusing the digital infrastructure company of major accounting manipulations, on Monday said it has received a subpoena.

Redwood cityUnited statesNew yorkBen foldyColin kellaherHindenburg researchCarl icahn enterprisesAdani groupNorthern districtCarl icahnDow jones

Pacira s PCRX-201 Gets FDA RMAT Designation in Knee Osteoarthritis

By Colin Kellaher Pacira BioSciences has won a key U.S. Food and Drug Administration designation for its PCRX-201 gene-therapy product candidate for the treatment of osteoarthritis of the.

Pacira biosciencesColin kellaherDrug administrationDow jones

PureTech Gets FDA Orphan Designation for LYT-200 in Acute Myeloid Leukemia

By Colin Kellaher PureTech Health has won U.S. Food and Drug Administration orphan-drug designation for its LYT-200 drug candidate for the treatment of acute myeloid leukemia. The Boston.

United statesColin kellaherDrug administrationPuretech healthTech healthDow jones

2seventy Bio Shares Fall on Concerns About FDA Panel s Meeting on Abecma Gene Therapy

2seventy Bio Shares Fall on Concerns About FDA Panel s Meeting on Abecma Gene Therapy
morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.

United kingdomColin kellaherBristol myersDrug administrationDow jones company incBristol myers squibbRegeneron pharmaceuticalsDow jones

Applied Materials Raises Quarterly Dividend by 23%

By Colin Kellaher Applied Materials board has raised the semiconductor equipment maker s quarterly dividend by 25%, to 40 cents a share from 32 cents. The new quarterly payout, equal to.

Colin kellaherSanta claraDow jones

vimarsana © 2020. All Rights Reserved.